Dr. Leana Wen, Baltimore, MD (2025)

11/13/2025

The class of medicines known as GLP-1s have transformed clinical practice and shifted public perception to view obesity as a chronic disease that merits medical management.

Growing research is demonstrating that the potential of GLP-1s extends far beyond obesity care. Some benefits are already well-established and represent extraordinary medical advances that deserve greater attention, while others remain speculative and at risk of being overly hyped. Clinicians and patients alike should focus on what is firmly supported by evidence while maintaining healthy skepticism toward uses that have not yet been proven.

More in this week’s Washington Post column: https://www.washingtonpost.com/opinions/2025/11/11/glp-1-weight-loss-drugs-obesity

The medications aren’t just for diabetes and obesity, but they also aren’t for every ailment.

10/14/2025

More than 1 in 3 Americans have already used chatbots to research medical concerns. While there are real risks associated with them, and they should not be used to replace care from medical professionals, AI can help patients manage their health more effectively.

My latest Washington Post column has guidance on how you can best use these tools to support your care — and when you should proceed with caution. (Featuring comments from Dsr. Eric Topol and Adam Rodman.)

https://www.washingtonpost.com/opinions/2025/10/14/ai-chatbots-health-care-diagnoses/

Chatbots can help patients with their health, when used with caution

08/15/2025

There is a sense of fear and futility among many American scientists. Billions of dollars in federal grants to universities have been frozen or slashed. Thousands of scientists across federal agencies have been terminated.

Against this backdrop, the Aix-Marseille University in France is welcoming America’s “scientific refugees” with open arms. The "Safe Place for Science" program is tasked with recruiting American researchers and providing them with three years of dedicated funding. In three weeks, the program received about 300 applications; in total, it has some 600 applicants, including scientists from universities such as Harvard, Columbia, Stanford and Johns Hopkins.

More in this Washington Post column:

As the Trump administration cuts science jobs and funding, this university is offering to a new home.

Address

Baltimore, MD

Website

https://www.washingtonpost.com/people/leana-s-wen/

Alerts

Be the first to know and let us send you an email when Dr. Leana Wen posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Dr. Leana Wen:

Dr. Leana Wen